MilliporeSigma, the Life Science business of Merck KGaA in the U.S. and Canada, has announced a definitive agreement to acquire HUB Organoids Holding B.V. (HUB). This acquisition marks a significant step forward in enhancing their 2D and 3D cell culture portfolio with the innovative technology of
The pharmaceutical industry is currently experiencing a transformative period marked by evolving clinical trial dynamics, increased R&D investment, and significant post-pandemic adjustments. This transformation is primarily driven by the complexities of modern trials, the demands for personalized
The Europe Plant Cell Culture Equipment Market is poised for significant growth from 2024 to 2031. This article delves into the various facets of this burgeoning market, providing a comprehensive analysis that includes market dynamics, product segmentation, regional insights, competitive landscape,
Synthetic biology represents a revolutionary discipline that applies engineering principles to biology, aiming to develop cells into sophisticated micro-factories capable of producing essential materials. With the potential to spearhead advancements across numerous industries—including medicine,
Clinical laboratories today are navigating a landscape rife with challenges that necessitate a reevaluation of traditional operations. The healthcare industry is experiencing significant strain due to workforce shortages, soaring demands for test accuracy, and an increasing volume of diagnostic
The integration of large language models (LLMs) in health systems has the potential to revolutionize the way healthcare is delivered. Researchers at the Icahn School of Medicine at Mount Sinai have conducted a study to explore cost-effective strategies for implementing these advanced AI tools. The
